Darwin Global Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
OAG
Darwin Global Management's INSM Position: Q2 2026 in Review
Darwin Global Management reduced its Insmed (INSM) stake by 62% in Q2 2026, selling an estimated $1.26B and leaving 6,431,163 shares worth $674M. The position accounts for 17.91% of the portfolio, ranked #2.
Darwin Global Management first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.64B in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Darwin Global Management held 6,431,163 shares of Insmed worth $674M as of Q2 2026.
- Darwin Global Management sold 10,374,021 Insmed shares in Q2 2026, an estimated $1.26B.
- Insmed made up 17.91% of Darwin Global Management's portfolio in Q2 2026, its #2 holding.
- Darwin Global Management first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
- Darwin Global Management's Insmed position peaked at $3.64B in Q4 2025.
- 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Darwin Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.